Erie Insurance Group
ERIE
$255.56
-1.86%
Erie Indemnity Co is a property and casualty insurance holding company that primarily provides sales, underwriting, and policy issuance services on behalf of the Erie Insurance Exchange, focusing on auto, homeowners, and commercial insurance products across the United States. As a key service provider to the Exchange, Erie Indemnity holds a unique position in the insurance value chain, with its revenue tied to the performance and growth of the Exchange's policies. The stock is currently under scrutiny as it has experienced a significant decline over the past year, despite a recent rebound, with investors debating whether the pullback represents a value opportunity or reflects underlying challenges in the insurance cycle. The company's low beta and consistent dividend payments make it a defensive play, but its recent volatility and underperformance relative to the broader market have raised questions about its growth trajectory and competitive positioning.…
ERIE
Erie Insurance Group
$255.56
Investment Opinion: Should I buy ERIE Today?
Based on the available data, the recommendation is a Hold. The stock's forward PE of 18.6x suggests potential upside if earnings growth materializes, but the decelerating revenue growth and lack of analyst coverage introduce significant uncertainty. The average analyst target is not available, but the estimated EPS of $12.80 implies a forward PE of 20.3x at the current price, which is reasonable if achieved.
Sign up to view all
ERIE 12-Month Price Forecast
The AI assessment is neutral with medium confidence. The stock's valuation is not extreme, but the decelerating growth and lack of analyst coverage create uncertainty. The forward PE suggests the market expects earnings growth, but if that fails to materialize, the stock could decline further. Key factors to watch include revenue growth trends, earnings delivery, and any changes in analyst sentiment. An upgrade to bullish would occur if revenue growth accelerates above 5% and the forward PE remains below 20x; a downgrade to bearish would occur if revenue growth turns negative or earnings miss significantly.
Wall Street consensus
Given the minimal analyst data, we must state that insufficient analyst coverage is available to provide a meaningful consensus or target range. This limited coverage implies that Erie Indemnity may be under-researched, leading to less efficient price discovery and potentially higher volatility. Investors should rely on their own fundamental analysis and consider that the stock's low beta (0.3) and high dividend yield (1.9%) may attract income-focused investors, but the lack of analyst guidance adds uncertainty to the investment thesis.
Bulls vs Bears: ERIE Investment Factors
The bull case for Erie Indemnity rests on its strong profitability, defensive characteristics, and attractive forward valuation, while the bear case highlights decelerating growth, significant underperformance, and concentration risk. Currently, the bearish evidence appears stronger given the persistent revenue slowdown and the stock's 25.9% decline over the past year, which suggests underlying challenges beyond market sentiment. The most critical tension is whether the expected earnings growth (implied by the forward PE) will materialize; if it does, the stock is undervalued, but if not, the current valuation may still be too high. Investors should closely monitor quarterly earnings to see if revenue growth can reaccelerate and justify the forward multiple.
Bullish
- Forward PE below trailing: The forward PE of 18.6x is significantly lower than the trailing PE of 23.9x, implying the market expects substantial earnings growth (about 28%) over the next year. If this growth materializes, the stock is not expensive on a forward basis, offering potential upside.
- Strong profitability metrics: Erie Indemnity boasts a net margin of 13.75% and an operating margin of 17.69%, indicating efficient operations and strong pricing power. The ROE of 24.5% and ROA of 14.1% further underscore its ability to generate returns on shareholder equity and assets.
- Defensive characteristics: With a beta of 0.3 and a dividend yield of 1.9%, the stock offers defensive qualities that may appeal to income-focused investors. The low beta suggests lower volatility compared to the market, providing portfolio stability during turbulent times.
- Recent price rebound: The stock has rebounded 22.2% over the past three months, recovering from its 52-week low of $204.63. This momentum, coupled with a 4.8% gain in the last month, indicates improving investor sentiment and potential for further upside.
Bearish
- Significant underperformance vs market: Over the past year, ERIE has declined 25.9% while the S&P 500 gained 18.6%, a relative underperformance of over 44 percentage points. This suggests persistent negative sentiment and potential structural issues within the company or its sector.
- Decelerating revenue growth: Revenue growth slowed to 2.3% YoY in Q1 2026, down from 7.1% in Q1 2025. Sequential revenue declined from $1.067B in Q3 2025 to $1.012B in Q1 2026, indicating a weakening top-line trend that may pressure earnings.
- High valuation on trailing basis: The trailing PE of 23.9x is elevated relative to the broader market and historical norms for insurance companies. If earnings growth fails to meet expectations, the stock could face multiple compression, leading to further downside.
- Limited analyst coverage: With only 1 analyst covering the stock and no consensus recommendation, there is a lack of institutional oversight. This can lead to inefficient price discovery and higher volatility, as investors lack clear guidance on the company's prospects.
ERIE Technical Analysis
Erie Indemnity's stock is in a clear downtrend over the past year, with a 1-year price change of -25.9%, while the S&P 500 gained 18.6% over the same period. The current price of $260.40 sits at 72.8% of its 52-week range (between $204.63 low and $357.75 high), indicating that the stock is closer to its lows than its highs, suggesting a bearish or value-oriented positioning. This placement near the lower end of the range could signal either a potential value opportunity or a falling knife, depending on the fundamental outlook.
Beta
0.30
0.30x market volatility
Max Drawdown
-43.8%
Largest decline past year
52-Week Range
$205-$355
Price range past year
Annual Return
-27.9%
Cumulative gain past year
| Period | ERIE Return | S&P 500 |
|---|---|---|
| 1m | +5.6% | +2.7% |
| 3m | +23.1% | +1.0% |
| 6m | -6.1% | +12.0% |
| 1y | -27.9% | +18.9% |
| ytd | -8.0% | +12.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ERIE Fundamental Analysis
Erie Indemnity's revenue has shown modest growth, with the most recent quarter (Q1 2026) reporting revenue of $1.012 billion, up 2.3% year-over-year. However, this growth rate is decelerating compared to prior quarters, as Q3 2025 revenue was $1.067 billion and Q2 2025 was $1.060 billion, indicating a sequential decline. The company's revenue is primarily driven by policy issuance and renewal services, which contributed $786.4 million in the latest quarter, while service agreements added only $5.9 million, highlighting the core business's reliance on the Exchange's policy growth.
Quarterly Revenue
$1.0B
2026-03
Revenue YoY Growth
+2.3%
YoY Comparison
Gross Margin
14.5%
Latest Quarter
Free Cash Flow
$536999000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ERIE Overvalued?
Given that Erie Indemnity has positive net income, the PE ratio is the most appropriate valuation metric. The trailing PE is 23.9x, while the forward PE is 18.6x, implying that the market expects earnings growth of about 28% over the next year. This gap suggests that analysts anticipate a significant improvement in profitability, which is supported by the estimated EPS of $12.80 for the next fiscal year, up from the trailing EPS of $10.91. The forward PE of 18.6x is below the trailing PE, indicating that the stock is not expensive on a forward basis if the growth materializes.
PE
23.9x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 19x~53x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are moderate but notable. The company's revenue growth has decelerated to 2.3% YoY, and sequential revenue declined from $1.067B in Q3 2025 to $1.012B in Q1 2026, indicating a potential slowdown in policy issuance and renewal services. The net margin of 13.75% is solid, but the gross margin of 15.76% is relatively thin, leaving limited room for cost pressures. The company has no debt, which is a positive, but its payout ratio of 45.5% suggests a commitment to dividends that could strain cash flow if earnings decline. Free cash flow of $537M is positive, but it may not be sufficient to cover both dividends and growth investments if revenue growth continues to slow.